http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09309834-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69c0ba7037f9003fddd25919eee4a97a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baf849d216e689ecc40ccc931a7a7bc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6574
filingDate 1997-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990a18b76c4a01a0e6943c8baea291ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d787cf07a2ace202a08c4ab40c5ae7a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7681f1aa6f50ff2c3f6b6e7e3f3e10c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23d7122198e269fba14cba75aa813683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_241938d293e47e7308528cc65927489d
publicationDate 1997-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H09309834-A
titleOfInvention Manufacturing method of efonidipine hydrochloride preparation
abstract PROBLEM TO BE SOLVED: To provide a method for amorphizing efonidipine hydrochloride. SOLUTION: A mixture of efonidipine hydrochloride (I), hydroxypropylmethylcellulose acetate succinate and optionally a heat stabilizer is added to a mixture of 85-85%. 14 After heat treatment at 0 ° C or after A step of performing mechanochemical treatment at 0 to 140 ° C, dipping treatment in a solution containing water, impregnation treatment with a solution containing water, or contact treatment with a steam-containing gas is included. By performing the step B or by subjecting the mixture to steam treatment under high pressure at 100 to 140 ° C., a solid dispersion of efonidipine hydrochloride having high intestinal absorbability can be obtained as a solid dispersion in an amorphous state. . Further, by using high-frequency heating in the above step A, a solid dispersion of efonidipine hydrochloride having a high intestinal absorbability can be obtained as a solid dispersion in an amorphous state without using the step B. This manufacturing method has a remarkable manufacturing advantage that it does not require the use of an organic solvent. Embedded image
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7625948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7432392-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007108463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2007108463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009038112-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006118210-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5103173-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133513-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006064906-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8101774-B2
priorityDate 1996-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448654791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226668855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449488770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322421
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121950
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226683506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454668499
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID374122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21887872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420001215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420000504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20037692
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76963366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16091066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124604970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71398
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11764616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21267514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414059530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID374122

Total number of triples: 71.